| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |